Tag #Glp-1 Receptor Antagonists

What are the most significant health benefits and risks observed in the study of GLP-1 receptor antagonist drugs for patients with diabetes, and how do these findings compare to existing knowledge?

A large-scale study of 215,970 patients with diabetes using GLP-1 receptor antagonist drugs revealed a lower risk of 42 conditions, including cardiovascular disease, bacterial infections, psychotic disorders, and Alzheimer's, compared to other treatments. However, increased risks of nausea, vomiting, low blood pressure, and joint pain were also observed.